| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | +15.3% |
| Cost of Revenue | $6.4M | +18.6% |
| Gross Profit | $7.2M | +12.5% |
| R&D Expense | $18.3M | +21.1% |
| SG&A Expense | $6.8M | +62.8% |
| Operating Income | -$25.5M | -28.1% |
| Pre-tax Income | -$25.3M | -27.2% |
| Income Tax | $24K | +118.2% |
| Net Income | -$25.3M | -27.2% |
| EPS (Basic) | -$1.03 | +89.5% |
| EPS (Diluted) | -$1.03 | +89.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.5M | +24.8% |
| Inventory | $3.0M | +13.6% |
| Current Assets | $16.7M | +12.3% |
| Total Assets | $18.2M | +8.1% |
| Current Liabilities | $4.4M | +145.8% |
| Total Liabilities | $4.9M | +82.4% |
| Stockholders' Equity | $13.3M | +110.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.9M | -13.8% |
| Capital Expenditures | $90K | -41.2% |
| Investing Cash Flow | -$90K | +41.2% |
| Financing Cash Flow | $23.6M | +56.6% |
| Free Cash Flow | -$23.0M | -13.4% |